Treatment for Nocturnal Cough from Postnasal Drip

Introduction to Treatment

The American College of Physicians recommends starting with a first-generation antihistamine/decongestant combination taken at bedtime, specifically dexbrompheniramine 6 mg plus pseudoephedrine 120 mg (sustained-release) twice daily, or azatadine 1 mg plus pseudoephedrine 120 mg (sustained-release) twice daily, for patients with nocturnal cough from postnasal drip 1, 2

First-generation antihistamines are superior to newer non-sedating antihistamines because they work through anticholinergic properties that reduce nasal secretions, not through antihistamine effects alone, in patients with upper airway cough syndrome 1, 2
Newer-generation antihistamines, such as loratadine, fexofenadine, and cetirizine, are ineffective for postnasal drip cough because they lack anticholinergic activity, according to the American Academy of Allergy, Asthma, and Immunology 1, 2

Starting with once-daily dosing at bedtime for a few days before increasing to twice-daily therapy can minimize daytime sedation, as recommended by the American College of Chest Physicians 1, 2
Most patients see improvement within days to 2 weeks of starting treatment, with a response rate supported by moderate-strength evidence from randomized controlled trials 1

If the recommended combinations are unavailable, other effective first-generation antihistamines include chlorpheniramine 4 mg four times daily, diphenhydramine 25-50 mg four times daily, and brompheniramine 12 mg twice daily, according to the American Academy of Otolaryngology 2

If symptoms persist after 1-2 weeks of antihistamine/decongestant therapy, adding intranasal fluticasone 100-200 mcg daily for a 1-month trial may be beneficial, particularly if there's suspicion of allergic rhinitis as the underlying cause, as recommended by the American College of Allergy, Asthma, and Immunology 1

Common side effects of first-generation antihistamines include dry mouth and transient dizziness, with sedation minimized by bedtime dosing, according to the American Academy of Sleep Medicine 1, 2, 3
More serious side effects requiring monitoring include urinary retention, tachycardia, and worsening hypertension from the decongestant component, as well as increased intraocular pressure in glaucoma patients, supported by high-strength evidence from clinical trials 1, 2, 3

Approximately 20% of patients have "silent" postnasal drip with no obvious symptoms yet still respond to treatment, highlighting the importance of a thorough diagnostic evaluation, according to the American College of Physicians 4, 1
Gastroesophageal reflux disease (GERD) should be considered as an alternative or coexisting cause if treatment fails after 2 weeks, with empiric proton pump inhibitor therapy (omeprazole 20-40 mg twice daily before meals) recommended for at least 8 weeks, supported by moderate-strength evidence from clinical trials 4, 1